Management of women who test positive for high-risk types of human papillomavirus: the HART studyJack Cuzick, Peter Sasieni, George Terry et al.|The Lancet|2003Cited by 505
A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocolNicholas F. Brown, Paul Mulholland, Stasya Ng et al.|BMC Cancer|2020Cited by 51
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsySimona Balestrini, Fiona Byrne, Matthias J. Koepp et al.|Epilepsy & Behavior|2020Cited by 16
Chemoprevention of esophageal cancer with esomeprazole and aspirin therapy: Efficacy and safety in the phase III randomized factorial ASPECT trial.Janusz Jankowski, John de Caestecker, Sharon Love et al.|Journal of Clinical Oncology|2018Cited by 2
Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.Shibani Nicum, Claire Brooks, Rose Wharton et al.|Journal of Clinical Oncology|2013Cited by 1